ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · SONM

Atlas market file · Equity · United States

DNA X, Inc.SONM

Last close
3.96
Change
-0.75%
96-bar range
2.62 – 6.14
As of
6 Aug 2026

DNA X, Inc. is a telephone & telegraph apparatus issuer listed as SONM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:SONM

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

6.24565.31284.383.44722.514420 Mar29 May06 Aug

up candle   down candle

Latest close3.96
Day change-0.75%
Window high6.14
Window low2.62
96-bar change+18.21%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (-91.20% over the window).

69.14880.331219 Aug06 Aug

Source rail: Yahoo Finance chart API (SONM). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for SONM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

SONM public profile

Company

Telephone & telegraph apparatus issuer. DNA X, Inc. is connected to current market context, cited company sources and its retained research file.

Market

DNA X, Inc. trades as SONM on NASDAQ. DNA X, Inc. (SONM) has a latest verified close of 3.96, down 0.75%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files SONM under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

The Sonim XP10 rugged smartphone advertises itself as the best in extreme conditions, complete with a 5000mAh removable battery that promises to run applications longer than your average office phone can survive a Zoom call without overheating. Yet when you look at the numbers, the company's latest 10-Q shows it collected $16.2M in revenue for the quarter ending 30 September 2025, a tidy sum for a handset maker but one that sits awkwardly beside an inventory pile still valued at $11.0M and a net cash burn of $3.5M in operating activities for the quarter ending 31 March 2026. One handset's endurance story fails to cover the company's own cash-flow cliff, and shareholders are left wondering which gadget's battery they should be watching. (source: Sonim...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for DNA X, Inc. today

Open full report
SONM daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Sonim’s rugged phones and hotspots are built to survive where normal devices expire, and the company’s marketing material leans hard into phrases like “ultimate reliability” and “extreme conditions.” Yet the latest 10-Q for DNA X, Inc. (formerly Sonim Technologies) shows revenue of $16.2M for the quarter ending 30 September 2025, a figure that would sound healthier if the same filing did not also report $11.0M of inventory on hand, down only $3.8M from the prior year-end. The company burns $3.5M in operating cash for the quarter ending 31 March 2026, and its balance sheet shows $4.8M in assets against $4.9M in liabilities, leaving shareholders staring at a $983,000 deficit. The devices may be tough, but the company’s cash position is softer than a screen protector advertised for drop-proof use.

The XP10 rugged smartphone, Sonim’s flagship, touts a 5000mAh removable battery designed to keep mission-critical users online longer than a typical commute takes. That is a real product feature, but it doesn’t offset the reality that the company’s diluted EPS clocked in at $5.01 on only 1.3M shares in the quarter ending 31 March 2026. The optics look good, yet the cash register is quiet. Sonim’s product pages promise “unmatched durability,” yet the ledger promises more meetings with the CFO.

Between May and July 2026, Sonim filed a flurry of 8-Ks covering inventory movements, share issuance, and executive disclosures. The most eye-catching is the 8-K/A filed on 9 July 2026, which restated certain inventory and cost-of-goods-sold figures from earlier filings. The company also disclosed a net income attributable to parent of $6.3M for the quarter ending 31 March 2026, alongside an operating loss of $3.6M. The positive net income is welcome, but it sits beside a $1.2M cash balance and a continuing operating cash outflow. The gap between polished platform messaging and plain financials has never been clearer.

If you’re looking for a chart route, the company’s equity trades on the OTCQB under the symbol DNAX. The filings do not supply intraday price ranges or volume data, so any attempt to draw technical levels would be speculation. The market mechanism remains thin, and the primary source of price discovery remains the quarterly and current reports that Sonim itself files. Until the company moves to a national exchange or publishes more granular liquidity data, the best view of its equity is the same place investors have always looked: the SEC’s EDGAR archive.

What changed this week: Sonim restated certain inventory and COGS figures in an 8-K/A filed on 9 July 2026, updating earlier disclosures from the 8-K on 2 July 2026. The restatement does not alter the net income or EPS figures already reported for the quarter ending 31 March 2026, but it does tighten the company’s cost accounting and may prompt further questions from auditors. The company’s product pages remain unchanged, still advertising rugged phones, hotspots, and accessories designed for “ultimate reliability.” The evidence does not support any claim of new product launches, customer wins, or supply-chain breakthroughs in the supplied rail.

What remains unproven: Sonim’s ability to convert its inventory into cash at scale, its path to sustained profitability, and whether the $5.01 EPS on 1.3M shares is a one-off accounting artefact or the start of a trend. The company’s filings do not disclose segment-level revenue, customer concentration, or guidance, so investors are left to infer performance from broad labels like “Revenues” and “Revenue from Contract with Customer, Excluding Assessed Tax.” Until the company publishes a more detailed breakdown or a credible cash-flow forecast, the story remains one of potential tempered by thin disclosure.

What would deepen the file: a quarterly 10-Q with segment-level revenue, an updated inventory ageing schedule, a cash-flow bridge from operations to investing, and a clear articulation of capital allocation-whether to inventory, R&D, or debt servicing. Until then, the best view is the one the company itself provides: the SEC’s EDGAR filings, where the numbers speak louder than the product slogans.

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
SONM
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

SONM technical readout

Trend strength (ADX 14)
25.5
Average true range (ATR 14)
0.4948
ATR as % of price
16.33%
Volatility compression (ATR14/ATR50)
0.82x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

SONM evidence rails

Atlas uses the specific public rails available for SONM: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on SONM

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for SONM Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep SONM research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

SONM FAQ

What is DNA X, Inc. (SONM)?DNA X, Inc. (SONM) has a latest verified close of 3.96, down 0.75%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...

DNA X, Inc. (SONM) has a latest verified close of 3.96, down 0.75%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for SONM?DNA X, Inc. (SONM) has a latest verified close of 3.96, down 0.75%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...

DNA X, Inc. (SONM) has a latest verified close of 3.96, down 0.75%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files SONM under USA Stocks for browsing.

How often is the SONM page updated?The SONM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The SONM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for SONM?The SONM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:SONM. SEC EDGAR provides the filing anchor for this issuer. The page separates...

The SONM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:SONM. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on SONM?Yes. The workstation can open SONM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open SONM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this SONM page investment advice?No. The SONM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The SONM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →